In New York, VIOME, the AI-powered wellness service, raised a $15 million Series A round to launch its at-home health kit, specifically targeting the microbiome. This round brings VIOME’s total funding to $21 Million, led by Khosla Ventures with participation from Bold Capital Partners.
VIOME uses state-of-the-art proprietary technology licensed exclusively through its partnership with the Los Alamos National Laboratory. Its services offer unparalleled visibility into the ecosystem of the body to create unique molecular profiles for its subscribers. VIOME identifies and quantifies all microorganisms in the gut, but more importantly, analyzes what they are actually doing. By applying machine learning to this analysis, VIOME then makes personalized nutritional recommendations to balance the gut microbiome and ecosystem inside the body.
VIOME currently has several thousand customers using the product in an early evaluation program. The company plans availability in the US, UK, Canada, India and Middle East starting in September.